A 9535

  • New York Assembly Bill
  • 2023 Regular Session
  • Introduced in Assembly
  • Assembly
  • Senate
  • Governor

Establishes a generic drug research and development laboratory and production facility and the empire state biosimilar insulin initiative

Abstract

Establishes a generic drug research and development laboratory and production facility to manufacture generic prescription drugs in the state and the empire state biosimilar insulin initiative, which will develop generic forms of the three most widely used forms of insulin.

Bill Sponsors (1)

Votes


No votes to display

Actions


Mar 20, 2024

Assembly

REFERRED TO HEALTH

Bill Text

Bill Text Versions Format
A9535 PDF HTML

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the New York Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.